CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim

Clin Mol Hepatol. 2012;18(2):203-212. Published online 2012 June 26 DOI: https://doi.org/10.3350/cmh.2012.18.2.203

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?

Tae Wan Kim, Hong Joo Kim, Chang Uk Chon, Hyun Sun Won, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim

Clinical and Molecular Hepatology. 2012;18(2):203

Link1 Link2 Link3

CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed

Ariel W. Aday, Nicole E. Rich, Arjmand R. Mufti, Shannan R. Tujios

Clinical Liver Disease. 2018;11(5):123-127

Link1 Link2

Low-dose captopril for patients with liver cirrhosis: What is low?

AndréA. Van Vliet, AB J.M. Donker

Gastroenterology. 1994;106(4):1131

Link1 Link2

Continuation of nonselective beta‐blockers for patients with liver cirrhosis and hemodynamic nonresponse?

Tilman Sauerbruch

Hepatology. 2017;66(4):1362-1363

Link1 Link2

Low Dose of Nonselective B Blockers may Reduce Risk of Death in Patients with Cirrhosis after an Episode of Spontaneous Bacterial Peritonitis

B.S. Madsen, A.D. Fialla, K.F. Nielsen, A. Krag

Journal of Hepatology. 2016;64(2):S654-S655

Link1 Link2

Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating β-blocker, in patients with cirrhosis and portal hypertension

D. Tripathi, G. Therapondos, H. F. Lui, A. J. Stanley, P. C. Hayes

Alimentary Pharmacology & Therapeutics. 2002;16(3):373-380

Link1 Link2 Link3

Effects of the beta-blocker, nadolol, on liver hemodynamics and function in patients with liver cirrhosis

Journal of Hepatology. 1985;1:S93

Link1 Link2

PRO (“The Window Is Open”): In patients with cirrhosis with prior variceal hemorrhage and ascites, the clinical benefits of nonselective beta-blockers outweigh the risks and should be prescribed

Danielle Tholey, Nitzan Roth, Thomas Schiano

Clinical Liver Disease. 2018;11(5):119-122

Link1 Link2

Comparison of the Effects of a Cardioselective and a Nonselective β-Blocker on Portal Hypertension in Patients with Cirrhosis

Patrick Hillon, Didier Lebrec, Cristina Muńoz, Michel Jungers, Gerard Goldfarb, Jean-Pierre Benhamou

Hepatology. 2007;2(5):528S-531S

Link1 Link2

The effects of carvedilol a nonselective beta —blocker on portal hemodynamics in cirrhosis

C. Fierbinteanu-Braticevici, M. Udeanu, D. Andronescu

Journal of Hepatology. 2003;38:58

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.